David Davidson, Chief Medical Officer at bluebird bio, Inc. (BLUE), sold 12,720 shares at $159.47 ($2.0M) on 2019-04-04, disclosed to the SEC on 2019-04-08.
Seasonal sale ($2.0M) by Chief Medical Officer — this insider has traded BLUE in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $159.47 | 2,623 | $418K | 20.5% |
| 2 | $159.47 | 2,623 | $418K | 20.5% |
| 3 | $160.22 | 2,704 | $433K | 21.3% |
| 4 | $160.22 | 2,704 | $433K | 21.3% |
| 5 | $161.14 | 1,033 | $166K | 8.2% |
| 6 | $161.14 | 1,033 |
| $166K |
| 8.2% |
| Total | $160.06 avg | 12,720 | $2.0M | 100% |
| Filing → |
| BLUE | SELL | 2021-02-18 | $20K | — | Filing → |
| BLUE | SELL | 2021-02-04 | $3K | — | Filing → |
| BLUE | SELL | 2021-01-08 | $288K | — | Filing → |